87833-80-5

Usage

Uses

Used in Textile Industry:
1-Amino-4-phenylnaphthalene is used as a precursor for the production of dyes, specifically for dyes used in the textile industry.
Used in Organic Synthesis and Chemical Research:
1-Amino-4-phenylnaphthalene is also utilized in the field of organic synthesis and chemical research for its potential applications.
However, it is important to note that 1-Amino-4-phenylnaphthalene has been associated with health hazards, as it is classified as a possible carcinogen and can cause skin and eye irritation. Therefore, proper safety precautions should be taken when handling and using this chemical.

Upstream product

• 33457-01-1 1-nitro-4-phenyl-naphthalene 
• 6921-40-0 1-azidonaphthalene 
• 71-43-2 benzene 
• 86-57-7 1-Nitronaphthalene 
• 2298-07-9 4-Bromo-1-naphthylamine 
• 98-80-6 phenylboronic acid 
• 529-34-0 3,4-dihydronaphthalene-1(2H)-one 
• 7469-40-1 1-phenyl-3,4-dihydronaphthalene 
• 605-02-7 1-phenylnaphthalene 

Downstream Products

• 956285-35-1 4-phenylnaphthalene-1-sulfonic acid dimethylamide 
• 1407502-90-2 C₄₄H₂₉N₃ 
• 1407502-89-9 C₄₄H₂₉N₃ 
• 1407504-42-0 C₂₅H₁₆ClN 
• 1407504-41-9 C₁₉H₁₁Cl₂N 
• 949462-19-5 N-(biphenyl-4-yl)-4-phenylnaphthalen-1-amine 
• 856212-75-4 4-phenyl-naphthalene-1,2-diyldiamine 
• 36159-76-9 4-phenyl-1-naphthol 
• 109590-62-7 5-phenyl-1H-benz[g]indole-2,3-dione 

Relevant academic research and scientific papers

Aurora Kinase Modulators and Method of Use

The present invention relates to chemical compounds having a general formula I wherein A1-8, D′, L1, L2, R1, R6-8 and n are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of such kinases. For example, the compounds are capable of modulating Aurora kinase thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of Aurora kinase.

COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE

A compound for an organic optoelectronic device, an organic light emitting diode, and a display device, the compound being represented by the following Chemical Formula 1:

AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME

Provided are a novel aromatic amine derivative represented by the following general formula (1) and an organic electroluminescent device including an organic thin film formed of one or a plurality of layers including at least a light emitting layer interposed between a cathode and an anode, in which at least one layer of the organic thin film contains the aromatic amine derivative alone or as a component of a mixture, which contributes to suppressing molecular crystallization and improving yield in the production of an organic electroluminescent device, whereby an organic electroluminescent device having a long lifetime can be obtained, and the aromatic amine derivative is capable of realizing the organic electroluminescent device: where: R1 represents an aryl group or the like; a represents an integer of 0 to 4; b represents an integer of 1 to 3; and at least one of Ar1 to Ar4 represents a group represented by the following general formula (2): where Ar5 represents a fused aromatic ring group and Ar6 represents an aryl group or an aromatic heterocyclic group, where remaining groups of Ar1 to Ar4, none of which is represented by the general formula (2), each independently represent an aryl group or an aromatic heterocyclic group.

New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site

Discovery of the pyrazole-naphthyl urea class of p38 MAP kinase inhibitors typified by the clinical candidate BIRB 796 has encouraged further exploration of this particular scaffold. Modification to the part of the inhibitor that occupies the adenine/ATP

DIPROTONATION OF NITROARENES

Cryoscopic measurements shows that 1-nitronaphthalene is diprotonated in trifluoromethanesulfonic acid (TFSA).The diprotonated nitronaphthalenes are N,N-dihydroxyiminiumnaphthalenium dications, wich are fully characterised by UV, 1H-, 13/

Aromatic Substitution by Phenylnitrenium and Naphthylnitrenium Ions formed from Phenyl Azide and 1-Azidonaphthalene in the Presence of Trifluoromethanesulphonic Acid

Aromatic N-substitution by phenylnitrenium ions generated from phenyl azide in the presence of a catalytic amount of trifluoromethanesulphonic acid gave diarylamines (in especially good yield in the reaction with biphenyl or naphthalene), whereas naphthylnitrenium ions from 1-azidonaphthalene react with benzene to afford a C-substitution product, 1-amino-4-phenylnaphthalene.